Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Annals of the Rheumatic Diseases|May 30, 2025
EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 9, 2025
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of ArthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
RMD Open|February 11, 2026
Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysisSumera Qureshi, Maryam Adas, Phoebe J Cope, et al.
Nature Reviews. Rheumatology|January 25, 2018
Corrigendum: The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Nature Reviews. Rheumatology|December 8, 2017
The RA-MAP Consortium: a working model for academia-industry collaborationAndrew P Cope, Michael R Barnes, Alexandra Belson, et al.
Annals of the Rheumatic Diseases|May 30, 2025
EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 9, 2025
EULAR/American College of Rheumatology Risk Stratification Criteria for Development of Rheumatoid Arthritis in the Risk Stage of ArthralgiaHanna W van Steenbergen, Frank Doornkamp, Stefano Alivernini, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Pageof 19